Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer
Clinical trial NCT07752550 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07752550
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-07-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.